WNT signaling in activated microglia is proinflammatory

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Microglia activation drives neuroinflammation in neurological diseases.
• The molecular mechanisms of microglial proinflammatory transformation are not fully understood.
• Beta-catenin, a WNT signaling component, is implicated in various cellular processes.

Purpose of the Study:

• To investigate the role of beta-catenin and WNT signaling in microglial activation and proinflammatory transformation.
• To elucidate the molecular cascade of WNT signaling in microglia under neuroinflammatory conditions.
• To explore the therapeutic potential of targeting WNT/beta-catenin in neurodegenerative diseases.

Main Methods:

• Studied beta-catenin expression in microglia from Alzheimer's disease models (APdE9 mice).
• Utilized cultured mouse microglia to examine WNT-3A effects on WNT receptor signaling (FZD, LRP5/6).
• Performed gene-expression profiling to assess WNT-3A-induced changes in immune response genes.

Main Results:

• Increased beta-catenin expression observed in microglia from Alzheimer's-like pathology models.
• WNT-3A stimulation stabilized beta-catenin in microglia via LRP6 phosphorylation and downstream signaling.
• WNT-3A upregulated proinflammatory genes (IL-6, IL-12, TNF-α) and exacerbated their release.

Conclusions:

• WNT signaling, mediated by beta-catenin, promotes a proinflammatory phenotype in microglia.
• This pathway is active in disease conditions like Alzheimer's disease.
• Targeting WNT/beta-catenin signaling in microglia may offer a novel therapeutic strategy for neuroinflammation.